- Home
- SOPH vs AMRN Comparison
SOPH vs AMRN Comparison
Compare SOPH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- AMRN
- Stock Information
- Founded
- SOPH 2011
- AMRN 1989
- Country
- SOPH Switzerland
- AMRN Ireland
- Employees
- SOPH N/A
- AMRN N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- AMRN Health Care
- Exchange
- SOPH Nasdaq
- AMRN Nasdaq
- Market Cap
- SOPH 219.8M
- AMRN 216.0M
- IPO Year
- SOPH 2021
- AMRN 1993
- Fundamental
- Price
- SOPH $3.62
- AMRN $16.90
- Analyst Decision
- SOPH Buy
- AMRN Strong Sell
- Analyst Count
- SOPH 1
- AMRN 1
- Target Price
- SOPH $7.00
- AMRN $12.00
- AVG Volume (30 Days)
- SOPH 169.3K
- AMRN 174.2K
- Earning Date
- SOPH 08-05-2025
- AMRN 07-30-2025
- Dividend Yield
- SOPH N/A
- AMRN N/A
- EPS Growth
- SOPH N/A
- AMRN N/A
- EPS
- SOPH N/A
- AMRN N/A
- Revenue
- SOPH $67,173,000.00
- AMRN $214,112,000.00
- Revenue This Year
- SOPH $16.07
- AMRN N/A
- Revenue Next Year
- SOPH $22.94
- AMRN N/A
- P/E Ratio
- SOPH N/A
- AMRN N/A
- Revenue Growth
- SOPH 4.66
- AMRN N/A
- 52 Week Low
- SOPH $2.58
- AMRN $7.08
- 52 Week High
- SOPH $4.92
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- SOPH 70.98
- AMRN 71.53
- Support Level
- SOPH $2.81
- AMRN $16.12
- Resistance Level
- SOPH $3.40
- AMRN $17.49
- Average True Range (ATR)
- SOPH 0.30
- AMRN 0.96
- MACD
- SOPH 0.07
- AMRN 0.05
- Stochastic Oscillator
- SOPH 98.31
- AMRN 90.37
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.